文献速递神经肿瘤

COVID-19对2020年原发性脑及其他中枢神经系统肿瘤月度发病趋势的影响

The impact of COVID-19 on 2020 monthly incidence trends of primary brain and other CNS tumors.
PubMed 文献 · Neuro Oncol · 2024-01-01

本研究利用美国中央脑肿瘤登记处(CBTRUS)发病数据,分析COVID-19大流行第一年对原发性脑及其他中枢神经系统肿瘤发病的影响。研究比较2019与2020年按月年龄标化发病率和发病趋势,并按诊断年龄、性别、种族、民族、诊断确认方式、行为、肿瘤组织病理学和县级城市化分层。结果显示2020年3-5月发病率较2019年明显下降,主要由非恶性肿瘤驱动,2020年3月较2019年3月下降50%;胶质母细胞瘤月度发病率无变化。

要点

  • 2020年3-5月原发性脑及其他中枢神经系统肿瘤发病率较2019年同期明显下降。
  • 发病下降主要由非恶性肿瘤驱动,2020年3月较2019年3月下降50%。
  • 黑人个体2020年初发病率下降幅度大于白人个体,影像学确诊肿瘤下降幅度大于组织学确诊肿瘤。

核心结论

  • 2020年初原发性脑肿瘤总体发病率下降,作者认为这与COVID-19大流行相关的医疗照护中断(如政府和医疗机构的规定)有关。

研究设计与样本

  • 利用美国中央脑肿瘤登记处(CBTRUS)发病数据,分析COVID-19大流行第一年对原发性脑及其他中枢神经系统肿瘤发病的影响。
  • 确定2019年和2020年按月的年龄标化发病率和发病趋势,并按诊断年龄、性别、种族、民族、诊断确认方式、行为、肿瘤组织病理学和县级城市化分层。
  • 评估2020年与2019年按月发病率比值,并按相同因素分层分析。

主要发现

  • 总体上,2020年3-5月发病率较2019年同期明显下降。
  • 发病下降主要由非恶性肿瘤驱动,2020年3月至2019年3月发病率下降50%。
  • 黑人个体2020年初发病率下降幅度大于白人个体。
  • 影像学确诊肿瘤的发病下降幅度大于组织学确诊肿瘤。
  • 2020年胶质母细胞瘤月度发病率较2019年无变化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To mitigate disease spread, restrictions implemented in the United States surrounding the COVID-19 pandemic created an environment that led to delays in cancer diagnosis. The data needed to accurately analyze the impact of the pandemic on brain and CNS tumor incidence has not been available until now. Utilizing incidence data from the Central Brain Tumor Registry of the United States (CBTRUS) we analyzed the impact of the COVID-19 pandemic on primary brain and other CNS tumor incidence for the first year of the pandemic. METHODS: Monthly age-adjusted incidence rates and incidence trends for 2019 and 2020 were determined for age at diagnosis, sex, race, ethnicity, diagnostic confirmation, behavior, tumor histopathology, and county-level urbanization. Monthly incidence rate ratios comparing 2020 and 2019 were evaluated for the same factors. RESULTS: Overall, there was a notable decrease in incidence rates in March-May 2020 when compared to 2019. These decreases were driven by nonmalignant tumors, with a 50% incidence decrease between March 2020 and 2019. Individuals who were Black had a larger incidence decrease in early 2020 than individuals who were White. Radiographically confirmed tumors saw larger incidence decreases than histologically confirmed tumors. There were no changes in monthly incidence of glioblastoma in 2020 compared to 2019. CONCLUSIONS: These data provide evidence that disruptions in medical care, such as governmental and health care mandates, in response to the COVID-19 pandemic resulted in an overall decreased incidence of primary brain tumors in early 2020.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Cioffi G, Waite KA, Price M, et al. The impact of COVID-19 on 2020 monthly incidence trends of primary brain and other CNS tumors. Neuro Oncol. 2024. PMID: 38167948. doi:10.1093/neuonc/noad235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。